Quick Answer
TANDEM DIABETES CARE INC reported Diluted EPS of $3.04 per share (loss) for fiscal year 2025.
TANDEM DIABETES CARE INC Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$3.04 | -106.8% |
| 2024 | -$1.47 | +57.1% |
| 2023 | -$3.43 | -133.3% |
| 2022 | -$1.47 | -712.5% |
| 2021 | $0.24 | +142.9% |
| 2020 | -$0.56 | -33.3% |
| 2019 | -$0.42 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.31 | +11.4% | +60.3% |
| June 30, 2025 | -$0.78 | -66.0% | +60.4% |
| March 31, 2025 | -$1.97 | -203.1% | -462.9% |
| September 30, 2024 | -$0.35 | +31.4% | +25.5% |
| June 30, 2024 | -$0.47 | +14.5% | +27.7% |
| March 31, 2024 | -$0.65 | +66.1% | -27.5% |
| September 30, 2023 | -$0.51 | +32.9% | +7.3% |
| June 30, 2023 | -$0.55 | -129.2% | +71.4% |
- TANDEM DIABETES CARE INC showed a decrease of -106.8% in Diluted EPS compared to the prior fiscal year.
- Over the 2019–2025 period, TANDEM DIABETES CARE INC’s diluted eps has declined by 623.8% (from $0.42 per share (loss) to $3.04 per share (loss)).
- The most recent figure is from TANDEM DIABETES CARE INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: